KPRX — Kiora Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing
Kiora Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Kiora Pharmaceuticals Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals - Enters Exclusive Option Agreement With Senju - SEC Filing
Kiora Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Kiora Pharmaceuticals Inc expected to post a loss of 67 cents a share - Earnings Preview
Kiora Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
Kiora Pharmaceuticals Inc expected to post a loss of 55 cents a share - Earnings Preview
Kiora Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary
Kiora Pharmaceuticals Inc expected to post a loss of 76 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Receives Ind Approval To Initiate Abacus-2, A Phase 2 Clinical Trial Of Kio-301 For Treatment Of Retinitis Pigmentosa
Kiora Pharmaceuticals Inc reports results for the quarter ended in January - Earnings Summary
Kiora Pharmaceuticals Inc expected to post a loss of 86 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Says Certificate Of Amendment Effects A 1-For-9 Reverse Stock Split Of Company's Common Stock
Kiora Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Kiora Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview